Merkel Cell Carcinoma of the Scrotum
| Primary Site | Histology | Staging Type |
|---|---|---|
| C632 | 8247 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C632 Scrotum, NOS **Note 1:** This schema is based on the UICC chapter *Merkel Cell Carcinoma of Skin,* pages 177-180. **Note 2:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Skin Except Eyelid* chapter on page 172 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=172).Main Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Clinical T | Yes |
NAACCR #940
tnmClinT |
None | ||
| Clinical N | Yes |
NAACCR #950
tnmClinN |
None | ||
| Clinical M | Yes |
NAACCR #960
tnmClinM |
None | ||
| TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
| Pathologic T | Yes |
NAACCR #880
tnmPathT |
None | ||
| Pathologic N | Yes |
NAACCR #890
tnmPathN |
None | ||
| Pathologic M | Yes |
NAACCR #900
tnmPathM |
None | ||
| TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
| SSF1: Measured Thickness (Depth) | 988 | No |
NAACCR #2880
csSiteSpecificFactor1 |
CCCR/Canada COC |
None |
| SSF16: Size of Metastasis in Lymph Nodes | 999 | No |
NAACCR #2870
csSiteSpecificFactor16 |
CCCR/Canada COC SEER |
None |
| SSF17: Extracapsular Extension of Regional Lymph Nodes | 999 | No |
NAACCR #2871
csSiteSpecificFactor17 |
CCCR/Canada COC SEER |
None |
| SSF18: Isolated Tumor Cells (ITC) in Regional Lymph Node(s) | 999 | No |
NAACCR #2872
csSiteSpecificFactor18 |
CCCR/Canada COC SEER |
None |
| SSF19: Tumor Base Transection Status | 988 | No |
NAACCR #2873
csSiteSpecificFactor19 |
None | None |
| SSF20: Tumor Infiltrating Lymphocytes (TIL) | 988 | No |
NAACCR #2874
csSiteSpecificFactor20 |
None | None |
| SSF21: Growth Pattern of Primary Tumor | 988 | No |
NAACCR #2875
csSiteSpecificFactor21 |
None | None |
| SSF22: Profound Immune Suppression | 999 | No |
NAACCR #2876
csSiteSpecificFactor22 |
CCCR/Canada COC SEER |
None |
Additional Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | No |
NAACCR #390
dateOfDiagnosis |
None | ||
| Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
| Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
| Behavior | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
| RX Summ Systemic/Surgery Sequence | Yes |
NAACCR #1639
rxSummSystemicSurSeq |
None | ||
| RX Summ Surgery/Radiation Sequence | Yes |
NAACCR #1380
rxSummSurgRadSeq |
None | ||
| Regional Nodes Positive | Yes |
NAACCR #820
regionalNodesPositive |
None |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
| Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
| Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
| Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
| Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
| Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
| Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
| Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
| Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |